ID

12910

Beskrivning

L-Ascorbic Acid Depletion to Treat Acute Myeloid Leukemia and Myelodysplastic Syndromes; ODM derived from: https://clinicaltrials.gov/show/NCT00329498

Länk

https://clinicaltrials.gov/show/NCT00329498

Nyckelord

  1. 2016-01-06 2016-01-06 -
Rättsinnehavare

CC BY-NC 3.0

Uppladdad den

6 januari 2016

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :


Inga kommentarer

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Acute Myeloid Leukemia NCT00329498

Eligibility Acute Myeloid Leukemia NCT00329498

Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients should have aml or mds according to new who classification, with minimum of 5% blasts in peripheral blood.
Beskrivning

AML or MDS

Datatyp

boolean

Alias
UMLS CUI [1]
C0023467
UMLS CUI [2]
C3463824
there must be a clear and acceptable reason for not receiving standard treatments (chemotherapy and/or stem cell transplantation); or standard treatments have already been given and this option exhausted with evidence of refractory disease.
Beskrivning

Treatment history

Datatyp

boolean

Alias
UMLS CUI [1]
C0087111
prior treatments of any forms are allowed provided there is no potential residual beneficial effect and the patients are off treatment for at least 4 weeks, with estimated life expectancy of at least 2 months.
Beskrivning

Prior treatment

Datatyp

boolean

Alias
UMLS CUI [1]
C0087111
adequate amount (4 ml) of bone marrow sent to the laboratory for cell culture studies.
Beskrivning

Bone marrow

Datatyp

boolean

Alias
UMLS CUI [1]
C0005953
there are no restrictions based on age, sex, or ethnicity except that adequate contraception must be practiced in women of childbearing ages. although aml is rare in children, pediatric patients will be accepted.
Beskrivning

Further restrictions

Datatyp

boolean

Alias
UMLS CUI [1]
C0700589
there is no deficiency of g6pd (rbc).
Beskrivning

Deficiency of g6pd

Datatyp

boolean

Alias
UMLS CUI [1]
C0391941
asymptomatic patients with disease progression and symptomatic patients.
Beskrivning

Disease characteristics

Datatyp

boolean

Alias
UMLS CUI [1]
C0242656
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251

Similar models

Eligibility Acute Myeloid Leukemia NCT00329498

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
AML or MDS
Item
patients should have aml or mds according to new who classification, with minimum of 5% blasts in peripheral blood.
boolean
C0023467 (UMLS CUI [1])
C3463824 (UMLS CUI [2])
Treatment history
Item
there must be a clear and acceptable reason for not receiving standard treatments (chemotherapy and/or stem cell transplantation); or standard treatments have already been given and this option exhausted with evidence of refractory disease.
boolean
C0087111 (UMLS CUI [1])
Prior treatment
Item
prior treatments of any forms are allowed provided there is no potential residual beneficial effect and the patients are off treatment for at least 4 weeks, with estimated life expectancy of at least 2 months.
boolean
C0087111 (UMLS CUI [1])
Bone marrow
Item
adequate amount (4 ml) of bone marrow sent to the laboratory for cell culture studies.
boolean
C0005953 (UMLS CUI [1])
Further restrictions
Item
there are no restrictions based on age, sex, or ethnicity except that adequate contraception must be practiced in women of childbearing ages. although aml is rare in children, pediatric patients will be accepted.
boolean
C0700589 (UMLS CUI [1])
Deficiency of g6pd
Item
there is no deficiency of g6pd (rbc).
boolean
C0391941 (UMLS CUI [1])
Disease characteristics
Item
asymptomatic patients with disease progression and symptomatic patients.
boolean
C0242656 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial